James Edward Bass, Director at REATA PHARMACEUTICALS INC (RETA), bought 888 shares at $52.12 ($46K) on 2018-12-20, disclosed to the SEC on 2018-12-21.
Open-market purchase of $46k RETA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| RETA | BUY | 2018-07-26 | $139K | — | Filing → |
| RETA | BUY | 2017-11-16 | $187K | — | Filing → |
| RETA | BUY | 2017-08-01 | $250K | — | Filing → |